ABCAM PLC

("Abcam" or "the Company")

Non-Executive Director Remuneration

Director/PDMR Shareholding Notification

Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, was notified on 14 September 2017 that, each of its Non-Executive Directors ("NEDs") purchased ordinary shares of 0.2 pence each in the Company ("Shares") on 14 September 2017 at a price of £10.787260 per Share funded pursuant to individual fee agreements entered into by the NEDs with the Company on 15 October 2015 ("Fee Agreements"), details of which were set out in an announcement made by the Company on that date, under which the NEDs agreed to receive part of their fees delivered as a fixed number of Shares. 

Under the Fee Agreements, it was agreed that one third of the NEDs' initial total fees for Abcam's financial year ending 30 June 2017 would be delivered as Shares after deductions for PAYE and National Insurance following the announcement of the preliminary results for the year on 11 September 2017.  As announced on 15 October 2015, a fixed number of Shares were calculated for each NED by dividing one third of the total fees by the average Share price of £5.95 (being the average Share price for the ten dealing days following the announcement of Abcam's preliminary results for the year ended 30 June 2015).

Details of the number of shares purchased by each NED are set out below:

Each of the NEDs has committed not to transfer or sell the Shares during the term of their Non-Executive directorship. 

The Notification of Dealing Form for each PDMR can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014. 

For further information please contact: